The emerging clinical utility of ctDNA to guide adjuvant treatment in cancer
Lancet Reg Health West Pac
.
2025 Jun 5:59:101595.
doi: 10.1016/j.lanwpc.2025.101595.
eCollection 2025 Jun.
Authors
Emma Sanderson
1
2
,
Peter Gibbs
1
2
3
,
Jeanne Tie
1
3
4
Affiliations
1
Division of Personalised Oncology, Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.
2
Department of Medical Oncology, Western Health, Melbourne, Victoria, Australia.
3
Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Victoria, Australia.
4
Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
PMID:
40529817
PMCID:
PMC12173074
DOI:
10.1016/j.lanwpc.2025.101595
No abstract available